Sjogren’s Syndrome
Clinical Research Institute of Michigan – Shores Rheumatology Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201 Indication: Sjogren’s Syndrome Enrollment Status: Open Protocol: HZNP-DAZ-301, HZNP-DAZ-301 HZNP-DAZ-304 “Oasis” Drug: Dazodalibep Sponsor: Horizon/Amgen […]